This is an old revision of this page, as edited by Beetstra (talk | contribs) at 14:58, 24 November 2011 (Saving copy of the {{drugbox}} taken from revid 454010123 of page Oxymetazoline for the Chem/Drugbox validation project (updated: 'DrugBank').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 14:58, 24 November 2011 by Beetstra (talk | contribs) (Saving copy of the {{drugbox}} taken from revid 454010123 of page Oxymetazoline for the Chem/Drugbox validation project (updated: 'DrugBank').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)This page contains a copy of the infobox ({{drugbox}}) taken from revid 454010123 of page Oxymetazoline with values updated to verified values. |
Clinical data | |
---|---|
Trade names | Afrin, Dristan12-hrnasalspray, Ocuclear |
AHFS/Drugs.com | Monograph |
Pregnancy category |
|
ATC code | |
Pharmacokinetic data | |
Elimination half-life | 5-6 hours |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C16H24N2O |
Molar mass | 260.375 g·mol g·mol |
3D model (JSmol) | |
Melting point | 301.5 °C (574.7 °F) |
SMILES
| |
InChI
| |
(verify) |